BRD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.825410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.042800E-01
Normal-vs-Stage2
1.607800E-01
Normal-vs-Stage3
1.165200E-01
Normal-vs-Stage4
6.470500E-02
Stage1-vs-Stage2
3.043000E-01
Stage1-vs-Stage3
1.059790E-01
Stage1-vs-Stage4
1.213850E-01
Stage2-vs-Stage3
2.176600E-01
Stage2-vs-Stage4
5.544400E-01
Stage3-vs-Stage4
5.859400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.677190E-01
Normal-vs-AfricanAmerican
5.321000E-01
Normal-vs-Asian
4.270800E-01
Caucasian-vs-AfricanAmerican
4.863800E-01
Caucasian-vs-Asian
7.003800E-01
AfricanAmerican-vs-Asian
8.006600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.306600E-01
Normal-vs-Female
1.369200E-01
Male-vs-Female
6.978200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.234800E-01
Normal-vs-Age(41-60Yrs)
1.167850E-01
Normal-vs-Age(61-80Yrs)
2.376800E-01
Normal-vs-Age(81-100Yrs)
8.068000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.444000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.588400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.381600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.151800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.678600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.205200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.894370E-01
Normal-vs-Daily Drinker
1.671370E-01
Normal-vs-Weekly Drinker
3.393600E-01
Normal-vs-Occasional Drinker
4.109200E-01
Normal-vs-Social Drinker
7.364100E-02
Non Drinker-vs-Daily Drinker
6.117200E-01
Non Drinker-vs-Weekly Drinker
9.590200E-01
Non Drinker-vs-Occasional Drinker
5.401000E-01
Non Drinker-vs-Social Drinker
9.648600E-01
Daily Drinker-vs-Weekly Drinker
6.783400E-01
Daily Drinker-vs-Occasional Drinker
3.420600E-01
Daily Drinker-vs-Social Drinker
5.706400E-01
Weekly Drinker-vs-Occasional Drinker
6.859800E-01
Weekly Drinker-vs-Social Drinker
9.876400E-01
Occasional Drinker-vs-Social Drinker
5.686800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.600400E-02
Normal-vs-Grade 2
4.060800E-03
Normal-vs-Grade 3
6.763600E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.430200E-01
Grade 1-vs-Grade 3
4.272400E-01
Grade 1-vs-Grade 4
3.600400E-02
Grade 2-vs-Grade 3
5.531800E-01
Grade 2-vs-Grade 4
4.060800E-03
Grade 3-vs-Grade 4
6.763600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.501240E-01
Normal-vs-NonDiabetic
2.128000E-01
Diabetic-vs-NonDiabetic
5.067400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.810210E-01
Normal-vs-NoPancreatitis
1.905180E-01
Pancreatitis-vs-NoPancreatitis
7.717200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.728600E-01
Normal-vs-N1
1.470000E-01
N0-vs-N1
7.213200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.176200E-01
Normal-vs-TP53-NonMutant
5.145400E-01
TP53-Mutant-vs-TP53-NonMutant
3.080200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
